CURRICULUM VITAE RONALD E. DOMEN, MD PERSONAL DATA ...

49. Nifong TP, Domen RE. Oxygen saturation and Hemoglobin A content inpatients with sickle cell disease undergoing erythrocytapheresis. TherapeuticApheresis 2002;6:390-393.50. Nifong TP, Ehmann WC, Mierski JA, Domen RE, Rybka WB. Favorableoutcome after infusion of coagulase-negative Staphylococci-contaminatedperipheral blood hematopoietic cells for autologous transplantation. Archives ofPathology & Laboratory Medicine 2003;127:e19-e21.51. Domen RE, Hoeltge GA. Allergic transfusion reactions: an evaluation of273 consecutive reactions. Archives of Pathology & Laboratory Medicine2003;127:316-320.52. Domen RE, Smith ML. Professionalism and ethics in transfusion medicine:a focus on medical errors and patient safety. Blood Therapies in Medicine2003;3:42-48.53. Domen RE. Medicine and the arts: Night Owl, by M. Wyrebek;commentary by Ronald E. Domen. Academic Medicine 2004;79:184-185.54. Domen RE. Ethical issues in transfusion medicine: a focus on the safetyof blood and hematopoietic stem cell donation. Current Hematology Reports2005;4:465-469.55. Fung MK, Crookston KP, Wehrli G, Domen R, Lopez-Plaza I, Davenport R,Gottschall J, Spitalnik S for the AABB Taskforce on Transfusion MedicineResident Curriculum. Commentary: A proposal for curriculum content intransfusion medicine and blood banking education in pathology residencyprograms. Transfusion 2007;47:1930-1936.56. Domen RE, Wehler AB. An examination of professional and ethical issuesin the fellowship application process in pathology. Human Pathology2008;39:484-488.57. Alaishuski LA, Grim RD, Domen RE. The informed consent process inwhole blood donation. Archives of Pathology and Laboratory Medicine2008;132:947-951.58. Domen RE. Ethics and narrative medicine: who owns the story? TheInternational Journal of Healthcare & Humanities 2009;4(4):2-9 (Fall 2009).59. Uemura T, Riley TR, Khan A, Hollenbeak C, Schreibman I, Ghahramani N,Reeves B, Domen RE, Zander DS, Kadry Z. Immune functional assay forimmunosuppressive management in post-transplant malignancy. ClinicalTransplantation 2011; 25:E32-37.44